Mutational load distribution analysis (MLDA) in pancreatic cancer
No coordinating investigator defined.
No involved investigator sites defined.
Certain p16 mutation carriers showed mutation elevations in the specific Ki-ras and p53 alleles significantly higher than normal, similar to controls with pancreatitis. Two individuals from separate families started out with "low risk" readings subsequently converted to "high risk" categorization and remained there in each sequential exam.
There are currently no biomarkers annotated for this protocol.
No datasets are currently associated with this protocol.